immunoglobulin-based DNA vaccine (SAB Biotherapeutics/USAMRIID)

N/A

Report date: 2025/03/20 14:55:45

Base Information

Drug Nameimmunoglobulin-based DNA vaccine (SAB Biotherapeutics/USAMRIID)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHantavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSab Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSab Biotherapeutics IncUS Army Medical Research Institute of Infectious Diseases
Inactive CompaniesN/A
Active IndicationsHantavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A